Westfuller Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
VCM
ACG
EAM
JMFC
Westfuller Advisors's DNA Position: Q1 2026 in Review
Westfuller Advisors sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 1,698 shares — an estimated $14.1K sold.
Westfuller Advisors first reported a position in DNA in Q4 2025 and held it in 1 quarter. The position peaked at $14.1K in Q4 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.
- Westfuller Advisors reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
- Westfuller Advisors sold 1,698 Ginkgo Bioworks shares in Q1 2026, an estimated $14.1K.
- Westfuller Advisors first reported a position in Ginkgo Bioworks in Q4 2025 and held it in 1 quarter.
- Westfuller Advisors's Ginkgo Bioworks position peaked at $14.1K in Q4 2025.
- 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.
Based on Westfuller Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.